PTPRO - protein tyrosine phosphatase receptor type O Gene
Also Known as NPHS6; PTPU2; GLEPP1; PTP-OC; PTP-U2; PTPROT; R-PTP-O
Species: Homo sapiens
About PTPRO
This gene has 26 transcripts (splice variants), 220 orthologues, 35 paralogues and is associated with 2 phenotypes. Biased expression in kidney (RPKM 3.7), brain (RPKM 2.7) and 11 other tissues.
Summary
This gene encodes a member of the R3 subtype family of receptor-type Protein tyrosine phosphatases. These proteins are localized to the apical surface of polarized cells and may have tissue-specific functions through activation of Src family kinases. This gene contains two distinct promoters, and alternatively spliced transcript variants encoding multiple isoforms have been observed. The encoded proteins may have multiple isoform-specific and tissue-specific functions, including the regulation of osteoclast production and activity, inhibition of cell proliferation and facilitation of Apoptosis. This gene is a candidate tumor suppressor, and decreased expression of this gene has been observed in several types of Cancer. [provided by RefSeq, May 2011]
PTPRO Products (6)
| mRNA | Protein | Name |
|---|---|---|
| NM_002848.4 | NP_002839.1 | receptor-type tyrosine-protein phosphatase O isoform b precursor |
| NM_030667.3 | NP_109592.1 | receptor-type tyrosine-protein phosphatase O isoform a precursor |
| NM_030668.3 | NP_109593.1 | receptor-type tyrosine-protein phosphatase O isoform d |
| NM_030669.3 | NP_109594.1 | receptor-type tyrosine-protein phosphatase O isoform c |
| NM_030670.3 | NP_109595.1 | receptor-type tyrosine-protein phosphatase O isoform d |
| NM_030671.3 | NP_109596.1 | receptor-type tyrosine-protein phosphatase O isoform c |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables cadherin binding |
IPI
IPI: Inferred from physical interaction
|
28926625 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
19167335 | GOA |
| enables protein tyrosine phosphatase activity |
IDA
IDA: Inferred from direct assay
|
19167335 | GOA |
| enables protein tyrosine phosphatase activity |
IMP
IMP: Inferred from mutant phenotype
|
19233845 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in glomerulus development |
IMP
IMP: Inferred from mutant phenotype
|
21722858 | GOA |
| involved in monocyte chemotaxis |
IMP
IMP: Inferred from mutant phenotype
|
19233845 | GOA |
| involved in peptidyl-tyrosine dephosphorylation |
IMP
IMP: Inferred from mutant phenotype
|
19233845 | GOA |
PTPRO Protein Structure
fn3: Fibronectin type III domain (435 - 521)
fn3: Fibronectin type III domain (725 - 800)
Y_phosphatase: Protein-tyrosine phosphatase (962 - 1193)
- 0
- 200
- 400
- 600
- 800
- 1000
- 1216 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
receptor-type tyrosine-protein phosphatase O |
|
PTPRO Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
PTPRO | Q16827 | MET | Homo sapiens | P08581 | 19167335 | |
|
Intra
|
PTPRO | Q16827 | MET | Homo sapiens | P08581 | 28330616 |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Nephrotic Syndrome, Type 6 |
|
|
| Genetic Steroid-Resistant Nephrotic Syndrome |
|
|
| Focal Segmental Glomerulosclerosis |
|
|
| Nephrotic Syndrome |
|
|
| Focal Segmental Glomerulosclerosis 7 |
|
|
| Focal Segmental Glomerulosclerosis 9 |
|
|
| Familial Nephrotic Syndrome |
|
|
| Galloway-Mowat Syndrome |
|
|
| Alport Syndrome |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Canis familiaris | PTPRO | VGNC | VGNC:45195 |
| Macaca mulatta | PTPRO | VGNC | VGNC:100096 |
| Bos taurus | PTPRO | VGNC | VGNC:33555 |
| Felis catus | PTPRO | VGNC | VGNC:69179 |
| Rattus norvegicus | PTPRO | RGD | RGD:62068 |
| Mus musculus | PTPRO | MGD | MGI:1097152 |
| Others | PTPRO | NCBI |